Simona Saponara
C.V.

Frosini M., Sesti C., Saponara S., Donati A., Palmi M., Valoti M., Machetti F. and Sgaragli G.P. (2000) Effects of taurine and some structurally related analogues on the central mechanisms of thermoregulation. Adv. Exp. Med. Biol., 483, 273-282. (I.F. 0.513) ISSN 0065-2598 stampato in U.S.A.

Ponticelli F., Trendafilova A., Valoti M., Saponara S. and Sgaragli G.P. (2001). Synthesis and antiperoxidant activity of new phenolic O-glycosides. Carbohydr. Res, 330, 459-468. (I.F. 1.606) ISSN 0008-6215, stampato in Olanda.

Fusi F., Saponara S., Gagov H. and Sgaragli G.P. (2001). Effects of some sterically hindered phenols on whole-cell Ca2+ current of guinea pig gastric fundus smooth muscle cells. Br. J. Pharmacol., 132, 1326-1332. (I.F. 3.689) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Saponara S., Gagov H. and Sgaragli G.P. (2001). 2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+ channel via superoxide anion generation. Br. J. Pharmacol., 133, 988-996. (I.F. 3.689) ISSN 0007-1188, stampato in Gran Bretagna.

Petkov G.V., Fusi F., Saponara S., Gagov H., Sgaragli G.P. and Boev K.K. (2001). Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol. Scand., 173, 257-265. (I.F. 1.764) ISSN 0001-6772, stampato in Gran Bretagna.

Saponara S., Sgaragli G.P. and Fusi F. (2002). Quercetin as a novel activator of L-type Ca2+ channels in rat tail artery smooth muscle cells. Br. J. Pharmacol., 135, 1819-1827. (I.F. 3.45) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Saponara S., Sgaragli G.P., Cargnelli G. and Bova S. (2002). Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes. Br. J. Pharmacol., 137, 323-328. (I.F. 3.45) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Saponara S., Pessina F., Gorelli B. and Sgaragli G.P. (2003). Effects of quercetin and rutin on vascular preparations. A comparison between mechanical and electrophysiological phenomena. Eur. J. Nutr., 42, 10-17 (I.F. 2.130) ISSN 1436-6207, stampato in Germania.

Frosini M., Sesti C., Saponara S., Ricci L., Valoti M., Palmi M., Machetti F. and Sgaragli G.P. (2003). A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation. Br. J. Pharmacol., 139, 487-494 (I.F. 3.689) ISSN 0007-1188, stampato in Gran Bretagna.

Bova S., Cavalli M., Cima L., Luciani S., Saponara S., Sgaragli G., Cargnelli G. and Fusi F. (2003). Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles. Eur. J. Pharmacol., 470, 185-191 (I.F. 2.352) ISSN 0014-2999, stampato in Olanda.

Fusi F., Saponara S., Frosini M., Gorelli B. and Sgaragli G.P. (2003). L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles. Naunyn Schmiedeberg's Arch. Pharmacol., 368, 470-478 (I.F. 2.101) ISSN 0028-1298, stampato in Germania.

Saponara S., Kawase M., Shah A., Motohashi N, Molnar J., Ugocsai, K., Sgaragli G.P. and Fusi F. (2004). 3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility. Br. J. Pharmacol., 141, 415-422 (I.F. 3.325) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Sgaragli G. and Saponara S. (2005). Mechanism of myricetin stimulation of vascular L-type Ca2+ current. J. Pharmacol. Exp. Ther., 313, 790-797. (I.F. 4.335) ISSN 0022-3565, stampato in U.S.A.

Fusi F., Saponara S., Valoti M., Dragoni S., D’Elia P., Sgaragli T., Alderighi D., Kawase M., Shah A., Motohashi N and Sgaragli G. (2006). Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives. Curr. Drug Targets, 7, 949-959. (I.F. 4.274) ISSN 1389-4501, stampato in U.S.A.

Frosini M., Ricci L., Saponara S., Palmi M., Valoti M. and Sgaragli G.P. (2006). GABA-mediated effettcs of some taurine derivatives injected i.c.v. on rabbit rectal temperature and gross motor behavior. Amino Acids, 30, 233-242. (I.F. 2.000) ISSN 0939-4451, stampato in Austria.

Saponara S., Testai L., Iozzi D., Martinotti E., Martelli A., Chericoni S., Sgaragli G.P., Fusi F. and Calderone V. (2006). (+/-)-Naringenin as large conductance Ca2+-activated K+ (BKCa) channel opener in vascular smooth muscle cells. Br. J. Pharmacol., 149, 1013-1021. (I.F. 3.825) ISSN 0007-1188, stampato in Gran Bretagna.

Fusi F., Ferrara A., Sgaragli G. and Saponara S. (2007). Mechanisms of the antispasmodic activity of 3,5-di-t-butyl catechol (DTCAT) on rat vascular smooth muscles. Eur. J. Pharmacol., 561, 112-120. (I.F. 2.522) ISSN 0014-2999, stampato in Olanda.

Saponara S., Ferrara A., Gorelli B., Shah A., Kawase M., Motohashi N, Molnar J., Sgaragli G.P., Fusi F. (2007). 3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): A new multidrug resistance inhibitor devoid of effects on Langendorff-perfused rat heart. Eur. J. Pharmacol., 563, 160-163. (I.F. 2.522) ISSN 0014-2999, stampato in Olanda.

Fusi F., Ferrara A., Zalatnai A. Molnar J., Sgaragli G. and Saponara S. (2008). Vascular activity of two silicon compounds, Alis-409 and Alis-421, novel multidrug-resistance reverting agents in cancer cells. Cancer Chemother. Pharmacol., 61, 443-451 (I.F. 2.363) ISSN 0344-5704, stampato in Germania.

Saponara S., Sgaragli G.P., Fusi F. (2008) Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels. Eur. J. Pharmacol., 598, 75-80. (I.F. 2.522) ISSN 0014-2999, stampato in Olanda.

Bova S., Saponara S., Rampa A., Gobbi S., Cima L., Fusi F., Sgaragli G.P., Cavalli M., De los Rios C., Striessnig J., Bisi A. (2009). Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile J. Med. Chem., 52, 1259-1262 (I.F. 4.895) ISSN 0022-2623, stampato in USA.

Budriesi R., Cosimelli B., Ioan P., Ugenti M., Carosati E., Frosini M., Fusi F., Saponara S., Cruciani G., Novellino E., Spinelli D., Chiarini A. (2009). L-Type Calcium Channel Blockers: from Diltiazem to 1,2,4-Oxadiazol-5-ones via Thiazinooxadiazol-3-one Derivatives, J. Med. Chem., 52, 2352-2362 (I.F. 4.895) ISSN 0022-2623, stampato in USA.

Carosati E., Budriesi R., Ioan P., Cruciani G., Fusi F., Frosini M., Saponara S., Gasparrini F., Ciogli A., Villani C., Stephens P.J., Devlin F.J., Spinelli D., Chiarini A. (2009). Stereoselective Behavior of the Functional Diltiazem Analogue 1-[(4-Chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a New L-Type Calcium Channel Blocker. J. Med. Chem., 52, 6637-6648. (I.F. 4.895) ISSN 0022-2623, stampato in USA.

Fusi F., Cavalli M., Mulholland D., Crouch N.R., Coombes P., Dawson G., Bova S., Sgaragli G. and Saponara S. (2010) Cardamonin is a bifunctional vasodilator that inhibits Cav1.2 current and stimulates KCa1.1 in Rat Tail Artery Myocytes. J. Pharmacol. Exp. Ther., 332, 531-540 (I.F. 4.335) ISSN 0022-3565, stampato in U.S.A